Evidence map›Paper›PMID 28404792›Full record

ReviewClinical microbiology reviews2017

Mohamed-Ali Hakimi, Philipp Olias, L David Sibley

Open access · bronzeAbstract readReview
In one paragraph

Review in Clinical microbiology reviews, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 200 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
200citing papers in PubMed, 2 pooled it
30.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

200 citing papers in PubMed, 2 syntheses or guidelines pooled it, 346 citations in OpenAlex.

  1. A review of foodborneFrontiers in veterinary science · 2022
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. A single-cell atlas ofbioRxiv : the preprint server for biology · 2026
    Article
  12. Article
  13. Review
  14. mBio · 2026
    Article
  15. Dense granule proteins: key mediators ofFrontiers in medicine · 2026
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

140 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Mohamed-Ali HakimiInstitute for Advanced Biosciences, Team Host-Pathogen Interactions and Immunity to Infection, INSERM U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.
Philipp OliasDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA.
L David SibleyDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA sibley@wustl.edu.
Centre National de la Recherche Scientifique · FRUniversity of Bern · CHWashington University in St. Louis · US

Funding

Molecular Basis of Human ToxoplasmosisR01AI118426 · NIAID · WASHINGTON UNIVERSITY · PI SIBLEY, L. DAVID · 2015 to 2024
$6.0M
INHIBITION OF STAT TRANSCRIPTION BY TOXOPLASMAR21AI119744 · NIAID · WASHINGTON UNIVERSITY · PI SIBLEY, L. DAVID · 2017 to 2018
$419k
NIAID NIH HHS R01 AI118426NIAID NIH HHS R21 AI119744
6 · The paper itself

Abstract

Early electron microscopy studies revealed the elaborate cellular features that define the unique adaptations of apicomplexan parasites. Among these were bulbous rhoptry (ROP) organelles and small, dense granules (GRAs), both of which are secreted during invasion of host cells. These early morphological studies were followed by the exploration of the cellular contents of these secretory organelles, revealing them to be comprised of highly divergent protein families with few conserved domains or predicted functions. In parallel, studies on host-pathogen interactions identified many host signaling pathways that were mysteriously altered by infection. It was only with the advent of forward and reverse genetic strategies that the connections between individual parasite effectors and the specific host pathways that they targeted finally became clear. The current repertoire of parasite effectors includes ROP kinases and pseudokinases that are secreted during invasion and that block host immune pathways. Similarly, many secretory GRA proteins alter host gene expression by activating host transcription factors, through modification of chromatin, or by inducing small noncoding RNAs. These effectors highlight novel mechanisms by which

Indexed as

Signal TransductionTranscription, GeneticAnimalsHost-Parasite InteractionsHumansToxoplasmachromatin remodelingepigeneticsimmune evasioninnate immunityintracellular pathogenserine/threonine kinasessignal transductiontranscription factors

Identifiers

PMID28404792
PMCPMC5475222
OpenAlexW2606736166

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.